Objectives (Educational Content) :
1. Illustrate anatomy and function of healthy breasts and broadly discuss benign changes which can occur in adolescents. 2. Recognize benign breast masses and identify lesions which require a breast surgical consultation. 3. Explain how to refer to Breast Health Center.
Target Audience:
General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists, and nurses.
Identified Gap:
Identification and management of changes in breast health in adolescents.
Estimated Time to Complete the Educational Activity:
1 hour(s)
Expiration Date for CE/CME Credit:
02-10-2023
Method of Participation in the Learning Process:
The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.
Evaluation Methods:
All learners must successfully complete a post-test, as well as an activity evaluation, to claim CE/CME credit.
Disclosure:
Dr. Kaczynski has indicated that there are no relevant financial or other relationships with any commercial interests and that this activity was developed independent of commercial interest.
Accreditation Statement:
Children’s Hospital Medical Center of Akron is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.
CHMCA designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Bibliography:
•V. Murthy, S. Pawar, R. Chamberlain. Disease Severity, Presentation, and Clinical Outcomes Among Adolescents with Malignant Breast Neoplasms: A 20-Year Population-Based Outcomes Study from the SEER Database (1973-2009), Clin Breast Cancer. 2017 Aug. 17(5): 392-398.
•Bland, Copeland, Klimberg, Gradishar. The Breast. Elsevier 2018.
•UpToDate 2022
•The American Society of Breast Surgeons, Official Statement. Consensus Guideline on Concordance Assessment of Image-Guided Breast Biopsies and Management of Borderline or High-Risk Lesions. 2016